BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6510623)

  • 1. Vasodilators in left ventricular failure.
    Camerini F; Mestroni L; Neri R; Humar F
    G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
    Armstrong PW
    Can Med Assoc J; 1979 Oct; 121(7):913-8. PubMed ID: 497982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
    Solignac A
    Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Afterload reduction in the treatment of cardiac failure.
    Mason DT
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods for evaluating vasodilator agents in cardiac failure].
    Dahan M
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():63-7. PubMed ID: 2111689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
    Di Francesco GF; Baldoli E; Marchetti G; Glässer A
    Arzneimittelforschung; 1986; 36(1):84-8. PubMed ID: 3954821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of peripheral vasodilators with different mechanisms of action in treating heart failure patients].
    Novikov SV; Mareev VIu; Elizarova NA; Naumov VG; Sazonova LN
    Ter Arkh; 1987; 59(9):126-30. PubMed ID: 3424177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of heart failure with phentolamine (Regitin)].
    Imhof P
    Schweiz Med Wochenschr; 1977 Jul; 107(29):1041-3. PubMed ID: 897648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory heart failure with infusion of nitroprusside.
    Guiha NH; Cohn JN; Mikulic E; Franciosa JA; Limas CJ
    N Engl J Med; 1974 Sep; 291(12):587-92. PubMed ID: 4855255
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
    Francoual M
    Nouv Presse Med; 1979 Jan; 8(4):293-6. PubMed ID: 122024
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of vasodilator agents in the treatment of heart failure.
    Lloyd EA
    S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency].
    Weber S; Pailleret JJ; Cattan S; Guérin F; Degeorges M
    Ann Med Interne (Paris); 1985; 136(3):256-60. PubMed ID: 3927808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between drug-induced changes in central and regional hemodynamics in congestive heart failure.
    Cotsamire DL; Unverferth DV; Leier CV
    Can J Cardiol; 1986; 2(5):272-7. PubMed ID: 3768787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of dihydralazine in the treatment of chronic cardiac insufficiency].
    Morand P; Baudouy M; Camous JP; Gibelin P; Leborgne L
    Ann Med Interne (Paris); 1985; 136(3):266-71. PubMed ID: 4026112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy.
    Sutton FJ
    Am J Med; 1986 Feb; 80(2B):54-8. PubMed ID: 3511697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and use of vasodilators in the management of congestive heart failure.
    Lakier JB; Khaja F; Stein PD
    Am Heart J; 1979 Apr; 97(4):519-26. PubMed ID: 371379
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.